據(jù)MRCHUB網(wǎng)站12月7日莫斯科報道，根據(jù)國際文傳電訊社（Interfax）援引哈薩克斯坦工業(yè)和基礎(chǔ)設(shè)施開發(fā)部的新聞報道稱，該國預(yù)計將在西哈薩克斯坦地區(qū)建設(shè)一家生產(chǎn)甲醇的天然氣化工廠，作為1.4億美元項(xiàng)目的一部分。

該報道表示，哈薩克斯坦公司Zhaik Petroleum LTD在會議期間與中方簽署了EPC合同。該合同設(shè)想在西哈薩克斯坦地區(qū)建設(shè)一家產(chǎn)能為13萬噸的甲醇制氣化工企業(yè)。

在建設(shè)和組裝工作期間將創(chuàng)造約500個工作崗位，在設(shè)施投入運(yùn)行后將創(chuàng)造220個永久性工作崗位。該項(xiàng)目的總成本為1.4億美元。

這家新的天然氣化工工廠預(yù)計將于2024年底開始運(yùn)營。隨后，該項(xiàng)目將進(jìn)入第二階段，預(yù)計耗資2億美元，以啟動氨和尿素的生產(chǎn)。

早些時候有報道稱，11月8日，哈薩克斯坦國家天然氣公司在哈薩克斯坦西部的阿提勞啟動了一個年產(chǎn)50萬噸的聚丙烯的新工廠。該新工廠價值26億美元，將能夠生產(chǎn)多達(dá)65種聚丙烯，以滿足國內(nèi)需求，并出口聚丙烯到國外市場。其使用了由Lummus技術(shù)公司提供的Catofin和Novolen技術(shù)。

郝芬 譯自 MRCHUB

原文如下：

Methanol-making gas chemical facility worth USD140 mln to be built in Kazakhstan

A gas chemical enterprise to produce methanol is expected to be built in the West Kazakhstan region as part of a USD140-million project, said Interfax, citing the press service for the Kazakh Industry and Infrastructure Development Ministry.

"The Kazakh company Zhaik Petroleum LTD signed an EPC contract with the Chinese side during the meeting. This contract envisages the construction of a methanol-making gas chemical enterprise with a production capacity of 130,000 tonnes in the West Kazakhstan region," it said.

Some 500 jobs will be created during construction and assembly work, and 220 permanent jobs will be created after the facility is put into operation. The overall cost of the project stands at USD140 million.

The new gas chemical enterprise is expected to begin operating in late 2024. It will be followed by the project's second stage, estimated at USD200 million, to launch the production of ammonia and carbamide.

Earlier it was reported that on November 8, KazMunayGas launched a new plant for the production of polypropylene with a capacity of 500 thousand tons per year in Atyrau, Western Kazakhstan. The new plant is valued at USD2.6 billion and will be able to produce up to 65 types of polypropylene to meet domestic demand, as well as export polypropylene to foreign markets. It uses Catofin and Novolen technologies provided by Lummus Technology.